Sirolimus in de novo heart transplant recipients with severe renal impairment

Transpl Int. 2006 Mar;19(3):245-8. doi: 10.1111/j.1432-2277.2005.00258.x.

Abstract

Two patients with end-stage heart failure and advanced renal dysfunction (under chronic dialysis therapy) underwent heart transplantation. In order to avoid further renal impairment, a calcineurine inhibitor-free immunosuppression regimen based on the sirolimus was used. Although temporary perioperative support with hemofiltration and dialysis was needed, both patients eventually regained a reasonable renal function with no episodes of clinical rejection and normal cardiac function at 13 and 11 months, respectively, after transplantation. Sirolimus-based immunosuppression might be an interesting alternative to calcineurine inhibitors in the management of patients with significant renal impairment.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Calcineurin / metabolism
  • Calcineurin / pharmacology
  • Creatinine / metabolism
  • Dialysis
  • Heart Transplantation / methods*
  • Hemofiltration
  • Humans
  • Immunosuppressive Agents / pharmacology
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Diseases / complications*
  • Kidney Diseases / metabolism
  • Kidney Transplantation / methods*
  • Male
  • Middle Aged
  • Sirolimus / metabolism
  • Sirolimus / pharmacology
  • Sirolimus / therapeutic use*
  • Time Factors

Substances

  • Immunosuppressive Agents
  • Creatinine
  • Calcineurin
  • Sirolimus